Why ResMed's Rally Is Just Getting Started - Seeking Alpha
WEB3 days ago · The good news for ResMed is that GLP-1 drugs are no risk. Even better, ResMed's products improve patient outcomes! According to the company, which cites a SURMOUNT-OSA study, patients with GLP-1 ...
ResMed Inc. (RMD) Latest Stock News & Headlines - Yahoo …
WEBGet the latest ResMed Inc. (RMD) stock news and headlines to help you in your trading and investing decisions.
Resmed Stock Poised for Growth: Buy Rating Affirmed Amid …
WEBApr 17, 2024 · In a report released today, Lyanne Harrison from Bank of America Securities reiterated a Buy rating on Resmed (RMD – Research Report), with a price target of $220.00.
US FDA Identifies Recall of ResMed's Respiratory Devices as Most …
WEBJan 11, 2024 · (Reuters) - The U.S. Food and Drug Administration (FDA) on Thursday classified the recall of certain respiratory masks made by ResMed as most serious as their use could cause major injuries or...
ResMed Adopts New Operating Model to Accelerate Long-term …
WEBSAN DIEGO, November 9, 2023 – ResMed (NYSE: RMD, ASX: RMD) today announced a new operating model to accelerate long-term growth. The new operating model introduces dedicated leadership in Product, Revenue, and Marketing to the global executive team.
Newsroom | Resmed Inc
WEBAug 1, 2024 · At ResMed we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases.
ResMed Inc. Announces Results for the Second Quarter ... - ResMed …
WEBDec 31, 2023 · SAN DIEGO, Jan. 24, 2024 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended December 31, 2023. Second Quarter 2024 Highlights. All comparisons are to the prior year period. Revenue increased by 12% to $1.2 billion; up 11% on a constant currency basis.
ResMed Adopts New Operating Model to Accelerate Long-term …
WEBSAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced a new operating model to accelerate long-term growth. The new operating model introduces dedicated...
ResMed Inc. Announces Results for the Second Quarter of Fiscal …
WEBSAN DIEGO, Jan. 26, 2023 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended December 31, 2022. Second Quarter 2023 Highlights. All comparisons are...
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal …
WEBSAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended June 30, 2024. Fourth Quarter 2024 Highlights. All comparisons are to the prior year period. Revenue increased by 9% to $1.2 billion; up 10% on a constant currency basis.